Psicothema was founded in Asturias (northern Spain) in 1989, and is published jointly by the Psychology Faculty of the University of Oviedo and the Psychological Association of the Principality of Asturias (Colegio Oficial de Psicología del Principado de Asturias).
We currently publish four issues per year, which accounts for some 100 articles annually. We admit work from both the basic and applied research fields, and from all areas of Psychology, all manuscripts being anonymously reviewed prior to publication.
Rocío Romero1, Rocío Penas2, Ana García-Conde1, Pilar Llombart1, Sandra Pérez2, and José Heliodoro Marco3
1 Instituto Valenciano de Oncología (IVO),
2 Universidad Católica de Valencia, and
3 Universitat de Valencia
Objectives: The aim of this study is to analyse whether MBCT will reduce the general level of psychopathology, increase the quality of life, and increase meta-knowledge about their emotional state in Spanish participants with cancer. Method: The sample consisted of n = 88 Spanish oncology patients. This was a non-randomized, two-group (experimental vs waiting list) trial conducted in a naturalistic setting. We evaluated psychological distress (BSI-18), quality of life (FACT-G), and meta-knowledge of emotions (TMMS-24). Results: The participants who received the MBCT treatment improved more than the control group in distress (F= 6.79; p = .01, BSI-18), depression (F= 8.38; p = .005 ), quality of life -physical health (F = 5.56; p = .02), emotional state (F = 7.06; p= .01), and functional capacity (F = 7.98; p = .006), as well as meta-knowledge about their emotional state (F = 35.4; p = .01), and its subscales of perception, (F = 8.95; p = .004), comprehension, (F= 16.06; p = .01), and repair (F = 15.67; p = .01). Conclusions: The Bartley MBCT program was feasible and showed promise in improving general psychopathology (depression), improving patients’ quality of life, and increasing meta-knowledge about their emotional state.
Terapia Cognitiva Basada en Mindfullness en Pacientes Oncológicos Españoles: el Protocolo Bartley. Objetivos: el objetivo de este estudio es analizar el papel de la MBCT en la reducción de la psicopatología, la mejora de la calidad de vida y del metaconocimiento del estado emocional en participantes españoles oncológicos. Método: la muestra consta de n = 88 pacientes oncológicos españoles. Este es un ensayo no aleatorio de dos grupos (experimental versus lista de espera) realizado en un entorno hospitalario. Se evaluaron distrés psicológico (BSI-18), calidad de vida (FACTG) y metaconocimiento de las emociones (TMMS). Resultados: los participantes con tratamiento MBCT mejoraron más que el grupo control en distrés (F= 6.79; p = .01), depresión (F= 8.38; p = .005), en la calidad de vida asociada a salud física (F = 5.56; p = .02), al estado emocional (F = 7.06; p= .01) y a la capacidad funcional personal (F = 7.98; p = .006), y en metaconocimiento de las emociones (F = 35.4; p = .01), y sus subescalas percepción (F = 8.95; p = .004), comprensión, (F= 16.06; p = .01) y reparación (F = 15.67; p = .01). Conclusiones: la MBCT mostró resultados prometedores para mejorar la psicopatología general, la calidad de vida y el metaconocimiento sobre el estado emocional.
SPANISH
ENGLISH
https://doi.org/10.7334/psicothema2019.320